Sanofi Early Development Project Management Head (Immunology & Inflammation)

Mel was appointed Sanofi’s Early Development Project Management Head (Immunology & Inflammation) in July 2022 managing a global team of project managers and project planning managers. Following a biological sciences degree at Oxford University, a PhD and then two post-docs, Mel spent 10 years in Research at MedImmune (the former Biologics Organisation of AstraZeneca and initially Cambridge Antibody Technology) first as a Senior Scientist in Antibody Engineering and then as a Project Manager working predominantly on immuno-oncology projects such as Imfinzi. Mel then moved into Development in 2010, working as a Senior Project Manager on autoimmune projects such as tralokinumab with global teams, Wuxi and as part of the MedImmune Metabolic Disease and Cardio Vascular Leadership Team. Mel has been a VP/Senior Director/Director of Project Management at Kymab for the last seven years working as part of the Kymab Management Team (now the Site Leadership Team) and as the Global Project Manager for Amlitelimab (KY1005). She is a Fellow of the Association of Project Management.